JPS53142537A - Pharmacological treatment for habitual drug user by fusaric acid - Google Patents
Pharmacological treatment for habitual drug user by fusaric acidInfo
- Publication number
- JPS53142537A JPS53142537A JP5815978A JP5815978A JPS53142537A JP S53142537 A JPS53142537 A JP S53142537A JP 5815978 A JP5815978 A JP 5815978A JP 5815978 A JP5815978 A JP 5815978A JP S53142537 A JPS53142537 A JP S53142537A
- Authority
- JP
- Japan
- Prior art keywords
- pharmacological treatment
- fusaric acid
- drug user
- habitual
- habitual drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DGMPVYSXXIOGJY-UHFFFAOYSA-N Fusaric acid Chemical compound CCCCC1=CC=C(C(O)=O)N=C1 DGMPVYSXXIOGJY-UHFFFAOYSA-N 0.000 title 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000002650 habitual effect Effects 0.000 title 1
- 238000011458 pharmacological treatment Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Addiction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catching Or Destruction (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/797,410 US4124715A (en) | 1977-05-16 | 1977-05-16 | Method of pharmacologically treating drug addiction with fusaric acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS53142537A true JPS53142537A (en) | 1978-12-12 |
Family
ID=25170763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5815978A Pending JPS53142537A (en) | 1977-05-16 | 1978-05-16 | Pharmacological treatment for habitual drug user by fusaric acid |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4124715A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS53142537A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2821311A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2390957A1 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1103493B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4357330A (en) | 1981-07-30 | 1982-11-02 | Bristol-Myers Company | Pharmaceutical compositions |
| US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
| US5219858A (en) * | 1990-03-27 | 1993-06-15 | Parnell Pharmaceuticals, Inc. | Method and compositions for effecting withdrawal from drug dependency |
| US20040167164A1 (en) * | 1998-05-05 | 2004-08-26 | Jose Pozuelo | Compositions and methods for treating particular chemical addictions and mental illnesses |
| RU2209062C1 (ru) * | 2002-03-19 | 2003-07-27 | Институт физиологии им. И.П.Павлова РАН | Вещество, обладающее седативным действием |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3903285A (en) * | 1972-12-29 | 1975-09-02 | Microbial Chem Res Found | Method for treating parkinsonism |
-
1977
- 1977-05-16 US US05/797,410 patent/US4124715A/en not_active Expired - Lifetime
-
1978
- 1978-05-15 IT IT49359/78A patent/IT1103493B/it active
- 1978-05-16 DE DE19782821311 patent/DE2821311A1/de not_active Ceased
- 1978-05-16 FR FR7814463A patent/FR2390957A1/fr active Granted
- 1978-05-16 JP JP5815978A patent/JPS53142537A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2821311A1 (de) | 1978-11-30 |
| FR2390957A1 (fr) | 1978-12-15 |
| IT7849359A0 (it) | 1978-05-15 |
| US4124715A (en) | 1978-11-07 |
| FR2390957B1 (cg-RX-API-DMAC7.html) | 1981-12-11 |
| IT1103493B (it) | 1985-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2000136B (en) | Therapeutic agents | |
| GB2005248B (en) | Therapeutic agents | |
| ZA782816B (en) | Therapeutic agents | |
| GB2000138B (en) | Therapeutic agents | |
| GB2000131B (en) | Therapeutic agents | |
| JPS5462325A (en) | Pharmacological treatment of schizophrenia by alphaa methyllparaathyrosine | |
| PT68834A (en) | Process for preparing therapeutic agents | |
| JPS5439085A (en) | Therapeutically useful mmtrifluoroomethylphenyll piperadine derivative | |
| JPS53142535A (en) | Pharmacological treatment for medicinal poisoning by alphaamethyllparaa thyrosine | |
| ZA781511B (en) | Process for therapeutic treatment | |
| PT69012A (pt) | Process for preparing medicaments with prostaglandin-synthetases inhibiting activity | |
| ZA78413B (en) | New therapeutic agents | |
| GB2004290B (en) | Silicon-modified imidyl-phthalic acid derivatives | |
| JPS53142537A (en) | Pharmacological treatment for habitual drug user by fusaric acid | |
| PH14096A (en) | N-9,10-dihydrolysargyl-m-aminobenzoic acid dmide derivative | |
| GB2001076B (en) | Psychopharmacological peptides suitable for therapeutic administration | |
| GB2004876B (en) | Therapeutic agents | |
| PT68386A (en) | Alkaloid solution with pharmaceutical activity process for preparing a stable hydrogenated ergopeptide | |
| PH14956A (en) | Trans-broparestrol based therapeutic | |
| GB2007656B (en) | Therapeutic agents | |
| GB2003900A (en) | Silicon-modified bis-phthalic acid derivatives | |
| NZ184140A (en) | Pharmaceutical compositions based on a heterocyclic compound:treatment of skin disorders | |
| ZA786259B (en) | Therapeutic composition | |
| ZA78554B (en) | Novel therapeutic agents | |
| JPS5393683A (en) | Patient electrode |